Circulating cytokines present in the serum of peripheral arterial disease patients induce endothelial dysfunction

C. Botti, C. Maione, G. Dogliotti, P. Russo, G. Signoriello, A.M. Molinari, M.M. Corsi, V. Sica, G. Cobellis

Article ID: 6117
Vol 26, Issue 1, 2012
DOI: https://doi.org/10.54517/jbrha6117
Received: 8 April 2012; Accepted: 8 April 2012; Available online: 8 April 2012; Issue release: 8 April 2012

Abstract

Peripheral arterial disease (PAD) is a chronic condition caused by atherosclerosis and is a severe complication of type 2 diabetes (T2D). We hypothesised that chronic condition of arterial disease engenders inflammation and endothelial damage in response to circulating cytokines released in the blood stream of PAD patients. We explored the levels of circulating cytokines in PAD patients with and without diabetes by multiplex cytokine array compared with non-PAD controls. Serum from PAD patients with or without diabetes showed high levels of VEGF, IFN-gamma, TNF-alpha, MCP-1, and EGF. VEGF levels correlated with TNF-alpha and IFN-gamma, significantly. Endothelial cells (ECs) were exposed to the different altered cytokines to evaluate changes in cell growth, migration and tubule-like formation, displaying impairment on proliferation, migration and tubule formation. Our findings demonstrate that a set of cytokines is significantly increased in the serum of PAD patients. These cytokines act to induce endothelial dysfunction synergistically. VEGF strongly correlated with TNF-alpha and IFN-gamma, opening new therapeutic perspectives.


Keywords

peripheral arterial disease;cytokines;diabetes;inflammation


References

Supporting Agencies



Copyright (c) 2012 C. Botti, C. Maione, G. Dogliotti, P. Russo, G. Signoriello, A.M. Molinari, M.M. Corsi, V. Sica, G. Cobellis




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).